Skip to main content

Speaker announced for the Raymond and Beverly Sackler Foundation Distinguished Lecture in Neuroscience

9 May 2016

Brain cells in dish
An illustration of brain cells in a culture dish.

We are delighted to announce that Professor Jack Price, a leading expert in the field of neural stem cells at Kings College London, will be delivering our annual Raymond and Beverly Sackler Foundation Distinguished Lecture in Neuroscience, established in honour of Professor Sir Keith Peters.

Jack Price will deliver his lecture, titled Neurodiversity and autism: Can we model human development in a dish?, at 6pm on Monday 6th June at the University's Julian Hodge Building.

The lecture will be followed by a wine reception. It is free to attend, but registration is essential.

Book a ticket

Photograph of Professor Jack Price
Professor Jack Price

About Jack Price

Jack Price is a Professor of Developmental Neurobiology and Head of the Cells & Behaviour Unit at the Institute of Psychiatry Psychology & Neuroscience, King's College London. Following his PhD in Neurobiology at University College London, and post-doctoral training at MIT, he ran a research group at the National Institute for Medical Research, Mill Hill.

He was Director of Molecular Neuroscience at SmithKline Beecham Pharmaceuticals until joining King’s College London in 1998. He has published widely on neural stem cells as therapeutic agents, and has served on Working Parties on novel neurotechnologies with the Nuffield Council of Bioethics and the Academy of Medical Sciences.

He led the Department of Trade and Industry Technology Mission to China, Singapore, and South Korea, and served on BIONET, the European Commission project into governance of Biomedicine in Europe and China.

He is on the Scientific Advisory Board of the MRC Centre for Neuropsychiatric Genetics and Genomics at Cardiff University, and is a consultant to ReNeuron Ltd, a UK Biotech Company developing stem cell therapeutics.

Currently, he is part of three European consortia (EU-AIMS, StemBANCC, and MATRICS), funded by the European Commission, using stem cells to study brain disorders.

Share this story